Clinical Trials
3 trialsNCT05497843 2025-04-03
Chiauranib for Advanced or Unresectable Soft Tissue Sarcoma(STS)
Chipscreen Biosciences, Ltd.
Phase 2 Completed
NCT05336721 2025-03-24
A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC
Chipscreen Biosciences, Ltd.
Phase 2 Terminated
NCT03901118 2021-03-19
Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer
Chipscreen Biosciences, Ltd.
Phase 2 Completed